Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Hopkins

Showing results (191-200 of 202) with videos related to

Pageof 21
Sort By:
The New England Journal of Medicine|December 28, 2020
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care WorkersSheila F Lumley, Denise O'Donnell, Nicole E Stoesser, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026
Large outbreak of group B invasive meningococcal disease in young adults in South East England, March 2026Jessica I'Anson, Charlotte Anderson, Shona Arora, et al.
Health Technology Assessment (Winchester, England)|November 2, 2018
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCTGuy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2021
An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination StatusSheila F Lumley, Gillian Rodger, Bede Constantinides, et al.
Nature Communications|August 21, 2023
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection historyHailey Hornsby, Alexander R Nicols, Stephanie Longet, et al.
Scientific Reports|November 27, 2025
Dynamic impact of bivalent COVID-19 vaccine boosters on systemic and mucosal antibody and T cell immunityBarbara Kronsteiner, Melissa Govender, Chang Liu, et al.
The Lancet. Microbe|November 15, 2021
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort studyAdrienn Angyal, Stephanie Longet, Shona C Moore, et al.
The Lancet. Infectious Diseases|October 7, 2022
Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trialMartin J Llewelyn, Eric P Budgell, Magda Laskawiec-Szkonter, et al.
Cell|November 4, 2021
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccineRebecca P Payne, Stephanie Longet, James A Austin, et al.
The New England Journal of Medicine|January 31, 2019
Oral versus Intravenous Antibiotics for Bone and Joint InfectionHo-Kwong Li, Ines Rombach, Rhea Zambellas, et al.
Pageof 21

Showing results (191-200 of 202) with videos related to

Sort By:
Pageof 21
The New England Journal of Medicine|December 28, 2020
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care WorkersSheila F Lumley, Denise O'Donnell, Nicole E Stoesser, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026
Large outbreak of group B invasive meningococcal disease in young adults in South East England, March 2026Jessica I'Anson, Charlotte Anderson, Shona Arora, et al.
Health Technology Assessment (Winchester, England)|November 2, 2018
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCTGuy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2021
An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination StatusSheila F Lumley, Gillian Rodger, Bede Constantinides, et al.
Nature Communications|August 21, 2023
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection historyHailey Hornsby, Alexander R Nicols, Stephanie Longet, et al.
Scientific Reports|November 27, 2025
Dynamic impact of bivalent COVID-19 vaccine boosters on systemic and mucosal antibody and T cell immunityBarbara Kronsteiner, Melissa Govender, Chang Liu, et al.
The Lancet. Microbe|November 15, 2021
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort studyAdrienn Angyal, Stephanie Longet, Shona C Moore, et al.
The Lancet. Infectious Diseases|October 7, 2022
Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trialMartin J Llewelyn, Eric P Budgell, Magda Laskawiec-Szkonter, et al.
Cell|November 4, 2021
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccineRebecca P Payne, Stephanie Longet, James A Austin, et al.
The New England Journal of Medicine|January 31, 2019
Oral versus Intravenous Antibiotics for Bone and Joint InfectionHo-Kwong Li, Ines Rombach, Rhea Zambellas, et al.
Pageof 21